Contract 36E79726D0012
Radha Pharmaceuticals Inc · Department Of Veterans Affairs · December 10, 2025
Radha Pharmaceuticals Inc was awarded a federal contract by Department Of Veterans Affairs on December 10, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 10, 2025. If all options are exercised, the contract could reach $8.28 million.
Contract details
- PIID
- 36E79726D0012
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- December 10, 2025
- Latest action
- December 10, 2025
Description
NEW AWARD FOR BUPROPION HCL 12HR SA TABLETS WITH RADHA PHARMACEUTICALS INC. BASE YEAR ORDERING PERIOD IS MAY 16, 2026 TO MAY 15, 2027 WITH FOUR ONE-YEAR OPTIONS.
Modification timeline
-
December 10, 2025Base award$0
-
December 10, 2025Base award$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79726D0012?
Contract 36E79726D0012 is a federal contract awarded to Radha Pharmaceuticals Inc by Department Of Veterans Affairs on December 10, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36E79726D0012?
Radha Pharmaceuticals Inc won contract 36E79726D0012 from Department Of Veterans Affairs.
How much is contract 36E79726D0012 worth?
Contract 36E79726D0012 has obligated $0 to date but carries a potential ceiling of $8.28 million if fully funded and all options are exercised.